Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Marsh & McLennan Companies, Inc. (MMC) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Insurance Brokers
$181.82
-1.38 (-0.75%)Did MMC Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Marsh McLennan is one of their latest high-conviction picks.
Based on our analysis of 27 Wall Street analysts, MMC has a neutral consensus with a median price target of $203.50 (ranging from $181.00 to $258.00). The overall analyst rating is Buy (6.9/10). Currently trading at $181.82, the median forecast implies a 11.9% upside. This outlook is supported by 7 Buy, 14 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Brian Meredith at UBS, projecting a 41.9% upside. Conversely, the most conservative target is provided by Joshua Shanker at B of A Securities, suggesting a 0.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MMC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 4, 2025 | Citigroup | Matthew Heimermann | Neutral | Maintains | $201.00 |
| Nov 20, 2025 | Barclays | Alex Scott | Overweight | Upgrade | $206.00 |
| Nov 3, 2025 | B of A Securities | Joshua Shanker | Underperform | Downgrade | $181.00 |
| Nov 3, 2025 | TD Cowen | Andrew Kligerman | Hold | Maintains | $200.00 |
| Oct 20, 2025 | Goldman Sachs | Robert Cox | Neutral | Upgrade | $195.00 |
| Oct 17, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $212.00 |
| Oct 17, 2025 | Keefe, Bruyette & Woods | Meyer Shields | Market Perform | Upgrade | $191.00 |
| Oct 17, 2025 | Evercore ISI Group | David Motemaden | Outperform | Maintains | $237.00 |
| Oct 9, 2025 | JP Morgan | Jimmy Bhullar | Overweight | Upgrade | $242.00 |
| Oct 8, 2025 | UBS | Brian Meredith | Buy | Maintains | $257.00 |
| Oct 8, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $222.00 |
| Oct 8, 2025 | Barclays | Alex Scott | Equal-Weight | Maintains | $221.00 |
| Oct 7, 2025 | Morgan Stanley | Michael Phillips | Equal-Weight | Maintains | $215.00 |
| Sep 16, 2025 | Wolfe Research | Tracy Benguigui | Peer Perform | Initiates | $N/A |
| Aug 18, 2025 | Morgan Stanley | Michael Phillips | Equal-Weight | Maintains | $220.00 |
| Aug 13, 2025 | Citigroup | Matthew Heimermann | Neutral | Initiates | $226.00 |
| Jul 21, 2025 | Keefe, Bruyette & Woods | Meyer Shields | Underperform | Maintains | $210.00 |
| Jul 21, 2025 | UBS | Brian Meredith | Buy | Maintains | $258.00 |
| Jul 18, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $226.00 |
| Jul 10, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $229.00 |
The following stocks are similar to Marsh McLennan based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Marsh & McLennan Companies, Inc. has a market capitalization of $89.39B with a P/E ratio of 21.8x. The company generates $26.45B in trailing twelve-month revenue with a 15.6% profit margin.
Revenue growth is +11.5% quarter-over-quarter, while maintaining an operating margin of +19.2% and return on equity of +28.7%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Global leader in risk management and consulting.
The company operates through two primary segments: Risk & Insurance Services and Consulting. It generates revenue by providing insurance broking, reinsurance, and consulting services that help organizations manage risk and improve operational efficiency.
Marsh & McLennan has demonstrated strong revenue growth, particularly in 2025, due to successful performance across its divisions and strategic acquisitions. The firm serves a diverse clientele globally, positioning itself as a trusted partner in navigating complex business risks and regulatory challenges.
Financial Services
Insurance Brokers
90,000
Mr. John Quinlan Doyle
United States
1987
MMC expands its insurance solutions suite and presence in Hawai'i as Marsh McLennan Agency acquires three of the state's local insurance brokerages.
Marsh McLennan Agency expands in Hawai'i by acquiring three local insurance brokerages, enhancing its insurance solutions offerings.
MMC's acquisition boosts its market share and service offerings in Hawai'i, potentially increasing revenue and enhancing competitive positioning, which could positively impact stock performance.
Oliver Wyman and AEM's study shows declining sentiment among North America's industrial goods sector, particularly in construction and agricultural manufacturing, due to tariff unpredictability.
Declining sentiment among equipment manufacturers signals potential challenges in the industrial goods sector, impacting supply chains, pricing, and investment opportunities.
Zacks reports that insurance brokerage firms BRO, MMC, WTW, and AON are expected to benefit from rising insurance demand, strategic acquisitions, and technology adoption.
Increased demand for insurance, strategic acquisitions, and tech adoption can boost profitability and growth for these firms, potentially leading to higher stock prices and investor returns.
Marsh McLennan Agency has acquired multiple Honolulu-based insurance brokerages from Tradewind Group. Financial terms of the deal were not disclosed.
Marsh McLennan's acquisition expands its market presence in Hawaii, potentially increasing revenue and market share, signaling growth opportunities in the insurance sector.
MMC plans to leverage its consulting strengths and increasing estimates, alongside stable cash flow, to pursue ongoing growth opportunities.
MMC's reliance on consulting strength and rising estimates signals robust financial health, indicating potential for sustained growth and stable returns, appealing to investors seeking reliability.
Oliver Wyman, part of Marsh McLennan (NYSE:MMC), announced 40 new Partners and 4 new Executive Directors for 2026, emphasizing their client delivery and collaborative success.
The appointment of new leaders at Oliver Wyman signals strong management and strategic direction, which can enhance client trust and drive growth, positively affecting Marsh McLennan's stock performance.
Based on our analysis of 27 Wall Street analysts, Marsh & McLennan Companies, Inc. (MMC) has a median price target of $203.50. The highest price target is $258.00 and the lowest is $181.00.
According to current analyst ratings, MMC has 7 Buy ratings, 14 Hold ratings, and 1 Sell ratings. The stock is currently trading at $181.82. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict MMC stock could reach $203.50 in the next 12 months. This represents a 11.9% increase from the current price of $181.82. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates through two primary segments: Risk & Insurance Services and Consulting. It generates revenue by providing insurance broking, reinsurance, and consulting services that help organizations manage risk and improve operational efficiency.
The highest price target for MMC is $258.00 from Brian Meredith at UBS, which represents a 41.9% increase from the current price of $181.82.
The lowest price target for MMC is $181.00 from Joshua Shanker at B of A Securities, which represents a -0.5% decrease from the current price of $181.82.
The overall analyst consensus for MMC is neutral. Out of 27 Wall Street analysts, 7 rate it as Buy, 14 as Hold, and 1 as Sell, with a median price target of $203.50.
Stock price projections, including those for Marsh & McLennan Companies, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.